Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that ShockWave Medical will report an earnings per share (EPS) of $0.18.

Benzinga

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Expert Ratings for Insulet

Within the last quarter, Insulet (NASDAQ:PODD) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What's Going On With Telesat Shares Today

Telesat Corp (TSX:TSAT) (NASDAQ:TSAT) reported first-quarter revenue of C$185.77 million, a decline of 2.5% year-over-year. The revenue decrease was due to a reduction of service for one of Telesat's North American direct-to-home customers, termination and reductions on contract renewal of certain services, and a decline in equipment sales to Canadian government customers.…

Benzinga

Why Apple Shares Are Rebounding

Apple, Inc (NASDAQ: AAPL) opened lower on Friday and quickly lost short-term support at Thursday’s low-of-day and fell to a support level near the $154 level.

Benzinga

Insurance Stocks Moving In Friday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

ECOR: First Quarter 2022 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Google Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Alphabet. Looking at options history for Alphabet (NASDAQ:GOOGL) we detected 163 strange trades.

Benzinga

Is Formula One Stock A Buy Ahead Of Miami Grand Prix? Earnings, Netflix Renewal In Focus

The Formula One racing league announced a renewal with a major media company this week, posted earnings results and is preparing for a race in the U.S., a territory that has seen huge growth. Here’s the latest.

Benzinga

Why Sidus Space Shares Are Skyrocketing Today

Sidus Space, Inc. (NASDAQ:SIDU) signed a memorandum of understanding with Dhruva Space Private Limited to further the commercialization of space technologies and services. Sidus Space and Dhruva Space will explore collaborations to support the missions of the space programs in India and the U.S. through strategic alignment and value-add agreements. The agreement also…

Benzinga

SI-BONE's Earnings Outlook

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that SI-BONE will report an earnings per share (EPS) of $-0.43.

Benzinga

Preview: Radius Global Infr's Earnings

Radius Global Infr (NASDAQ:RADI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Radius Global Infr will report an earnings per share (EPS) of $-0.35.

Benzinga

Preview: Lincoln Educational Servs's Earnings

Lincoln Educational Servs (NASDAQ:LINC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Lincoln Educational Servs will report an earnings per share (EPS) of $0.04.

Benzinga

A Preview Of Adaptimmune Therapeutics's Earnings

Adaptimmune Therapeutics (NASDAQ:ADAP) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Adaptimmune Therapeutics will report an earnings per share (EPS) of $-0.22.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Preview: MTBC

MTBC (NASDAQ:MTBC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that MTBC will report an earnings per share (EPS) of $-0.27.

Benzinga

4 Analysts Have This to Say About NuVasive

Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter:

Benzinga

Earnings Outlook For Amicus Therapeutics

Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Amicus Therapeutics will report an earnings per share (EPS) of $-0.25.

Benzinga

Earnings Preview: Fulcrum Therapeutics

Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Fulcrum Therapeutics will report an earnings per share (EPS) of $-0.63.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Preview: Precision BioSciences's Earnings

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Precision BioSciences will report an earnings per share (EPS) of $-0.55.

Benzinga

Check Out What Whales Are Doing With UPST

A whale with a lot of money to spend has taken a noticeably bearish stance on Upstart Hldgs. Looking at options history for Upstart Hldgs (NASDAQ:UPST) we detected 18 strange trades.

Benzinga

Credit Suisse Maintains Outperform Rating for AppLovin: Here's What You Need To Know

Credit Suisse has decided to maintain its Outperform rating of AppLovin (NASDAQ:APP) and lower its price target from $112.00 to $100.00. Shares of AppLovin are trading down 4.02% over the last 24 hours, at $35.01 per share.

Benzinga

What 4 Analyst Ratings Have To Say About Opendoor Technologies

Opendoor Technologies (NASDAQ:OPEN) has observed the following analyst ratings within the last quarter:

Benzinga

Needham Maintains Buy Rating for Selecta Biosciences: Here's What You Need To Know

Needham has decided to maintain its Buy rating of Selecta Biosciences (NASDAQ:SELB) and lower its price target from $7.00 to $6.00. Shares of Selecta Biosciences are trading up 2.84% over the last 24 hours, at $0.83 per share.

Benzinga

Mid-Day Market Update: Dow Drops 250 Points; DMC Global Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones dropping 250 points on Friday.

Benzinga

Coinbase Global Whale Trades For May 06

A whale with a lot of money to spend has taken a noticeably bearish stance on Coinbase Global. Looking at options history for Coinbase Global (NASDAQ:COIN) we detected 44 strange trades.

1 … 536 537 538 539

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Defense

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.